US Patent 11079379 Methods of treating transthyretin (TTR) mediated amyloidosis
All edits
Edits on 31 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+252 characters)
Article
Patent abstract
Disclosed herein are methods for reducing or arresting an increase in a Neuropathy Impairment Score (NIS) or a modified NIS (mNIS+7) in a human subject by administering an effective amount of a transthyretin (TTR)-inhibiting composition.
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Patent Jurisdiction
Patent Number
110793790
Date of Patent
August 3, 2021
0Patent Application Number
201808030
Date Filed
August 3, 2018
0Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Patent Jurisdiction
Patent Number
110793790
Date of Patent
August 3, 2021
0Patent Application Number
201808030
Date Filed
August 3, 2018
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 8 Oct, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 11079379 Methods of treating transthyretin (TTR) mediated amyloidosis
Infobox
Is a
Patent applicant
Patent jurisdiction
Patent number
11079379
Date of patent
August 3, 2021
Patent application number
20180803
Date Filed
August 3, 2018
Find more entities like US Patent 11079379 Methods of treating transthyretin (TTR) mediated amyloidosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
